Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Goodwill (2020 - 2023)

Insight Molecular Diagnostics' Goodwill history spans 3 years, with the latest figure at $18.7 million for Q3 2022.

  • For Q3 2022, Goodwill rose 1.37% year-over-year to $18.7 million; the TTM value through Sep 2022 reached $18.7 million, up 1.37%, while the annual FY2021 figure was $18.7 million, 103.37% up from the prior year.
  • Goodwill for Q3 2022 was $18.7 million at Insight Molecular Diagnostics, roughly flat from $18.7 million in the prior quarter.
  • Across five years, Goodwill topped out at $24.2 million in Q2 2021 and bottomed at $9.2 million in Q1 2020.
  • The 3-year median for Goodwill is $18.4 million (2021), against an average of $14.8 million.
  • The largest annual shift saw Goodwill skyrocketed 163.82% in 2021 before it decreased 22.91% in 2022.
  • A 3-year view of Goodwill shows it stood at $9.2 million in 2020, then skyrocketed by 103.37% to $18.7 million in 2021, then changed by 0.0% to $18.7 million in 2022.
  • Per Business Quant, the three most recent readings for IMDX's Goodwill are $18.7 million (Q3 2022), $18.7 million (Q2 2022), and $18.7 million (Q1 2022).